Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.
McLaughlin S, Nakajima E, Bar Y, Hutchinson JA, Shin J, Moy B, Isakoff SJ, Bardia A, Kuter I, Spring LM.
McLaughlin S, et al. Among authors: spring lm.
Ther Adv Med Oncol. 2023 Jan 10;15:17588359221146133. doi: 10.1177/17588359221146133. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 36643653
Free PMC article.